Artículos por temáticas

Altered recruitment of motor cortex neuronal activity during the grasping phase of skilled reaching in a chronic rat model of unilateral Parkinsonism.

Hyland BI, Seeger-Armbruster S, Smither RA, Parr-Brownlie LC.

J Neurosci. 2019 Oct 21. pii: 0720-19. doi: 10.1523/JNEUROSCI.0720-19.2019. [Epub ahead of print]

Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's disease.

Torre-Muruzabal T, Devoght J, Van den Haute C, Brône B, Van der Perren A, Baekelandt V.

Acta Neuropathol Commun. 2019 Oct 22;7(1):160. doi: 10.1186/s40478-019-0814-3.

Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea.

Han S, Kim S, Kim H, Shin HW, Na KS, Suh HS.

BMC Public Health. 2019 Oct 22;19(1):1328. doi: 10.1186/s12889-019-7664-6.

Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson's disease.

Niccolini F, Wilson H, Giordano B, Diamantopoulos K, Pagano G, Chaudhuri KR, Politis M.

BMC Neurosci. 2019 Oct 22;20(1):55. doi: 10.1186/s12868-019-0537-1.

Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson's Disease Models.

Cho B, Kim T, Huh YJ, Lee J, Lee YI.

Int J Mol Sci. 2019 Oct 21;20(20). pii: E5208. doi: 10.3390/ijms20205208. Review.

Visual search and target detection during simulated driving in Parkinson's disease

Ranchet M, Morgan JC, Akinwuntan AE, Devos H.

Accid Anal Prev. 2020 Jan;134:105328. doi: 10.1016/j.aap.2019.105328. Epub 2019 Oct 19.

Decreased risk of Parkinson's disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis.

Zhu Y, Pu J, Chen Y, Zhang B.

PLoS One. 2019 Oct 22;14(10):e0224236. doi: 10.1371/journal.pone.0224236. eCollection 2019.

Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson's Disease.

Chen T, Liu W, Xiong S, Li D, Fang S, Wu Z, Wang Q, Chen X.

ACS Appl Mater Interfaces. 2019 Oct 29. doi: 10.1021/acsami.9b16047. [Epub ahead of print]

Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia

Junior NCF, Dos-Santos-Pereira M, Guimarães FS, Del Bel E.

Neurotox Res. 2020 Jan;37(1):12-29. doi: 10.1007/s12640-019-00109-8. Epub 2019 Oct 22.

Association between REM sleep behavior disorder and impulsive-compulsive behaviors in Parkinson's disease: a systematic review and meta-analysis of observational studies

Lu HT, Shen QY, Zhao QZ, Huang HY, Ning PP, Wang H, Xie D, Xu YM.

J Neurol. 2020 Feb;267(2):331-340. doi: 10.1007/s00415-019-09588-3. Epub 2019 Oct 21.

Impaired Fine Motor Function of the Asymptomatic Hand in Unilateral Parkinson's Disease.

Dan X, Liu J, Doyon J, Zhou Y, Ma J, Chan P.

Front Aging Neurosci. 2019 Oct 4;11:266. doi: 10.3389/fnagi.2019.00266. eCollection 2019.

Impaired Recognition of Facial Emotion in Patients With Parkinson Disease Under Dopamine Therapy

Palmeri R, Buono VL, Bonanno L, Allone C, Drago N, Sorbera C, Cimino V, di Lorenzo G, Bramanti A, Marino S.

J Geriatr Psychiatry Neurol. 2020 Sep;33(5):265-271. doi: 10.1177/0891988719882094. Epub 2019 Oct 21.

Decision under risk: Argument against early deep brain stimulation in Parkinson's disease.

Kim HJ, Jeon B.

Parkinsonism Relat Disord. 2019 Oct 10;69:7-10. doi: 10.1016/j.parkreldis.2019.10.008. [Epub ahead of print]

Predictors of Pisa syndrome in Chinese patients with Parkinson's disease: A prospective study.

Liu K, Ou R, Hou Y, Wei Q, Cao B, Song W, Zhao B, Shang H.

Parkinsonism Relat Disord. 2019 Oct 13;69:1-6. doi: 10.1016/j.parkreldis.2019.10.010. [Epub ahead of print]

Lesion of the Locus Coeruleus Damages Learning and Memory Performance in Paraquat and Maneb-induced Mouse Parkinson's Disease Model.

Hou L, Sun F, Sun W, Zhang L, Wang Q.

Neuroscience. 2019 Oct 18. pii: S0306-4522(19)30651-7. doi: 10.1016/j.neuroscience.2019.09.006. [Epub ahead of print]